Experiments were performed on uteri from estrogen-primed female rats. Bradykinin (BK) (10 ؊8 M) significantly augmented biosynthesis of prostaglandin F 2 ␣ (PGF 2 ␣) and prostaglandin E 2 (PGE 2 ), and this synthesis was completely blocked by N G -monomethyl L-arginine (NMMA) (300 M), a competitive inhibitor of nitric oxide synthase (NOS). Blockade of prostaglandin synthesis by indomethacin caused rapid dissipation of isometric developed tension (IDT) induced by BK. Blockade of NOS with NMMA had similar but less marked effects. Combining the two inhibitors produced an even more rapid decay in IDT, suggesting that BK-induced NO release maintains IDT by release of prostanoids. The decline of frequency of contraction (FC) was not significantly altered by either indomethacin or NMMA but was markedly accelerated by combination of the inhibitors, which suggests that PGs maintain FC and therefore FC decline is accelerated only when PG production is blocked completely by combination of the two inhibitors of PG synthesis. The increase in IDT induced by oxytocin was unaltered by indomethacin, NMMA or their combination indicating that neither NO nor PGs are involved in the contractions induced by oxytocin. However, the decline in FC with time was significantly reduced by the inhibitor of NOS, NMMA, suggesting that FC decay following oxytocin is caused by NO released by the contractile process. In the case of PGF 2 ␣, NMMA resulted in increased initial IDT and FC. The decline in FC was rapid and dramatically inhibited by NMMA. Receptor-mediated contraction by BK, oxytocin, and PGF 2 ␣ is modulated by NO that maintains IDT by releasing PGs but reduces IDT and FC via cyclic GMP.Nitric oxide (NO), a soluble gas, is synthesized by endothelial NO synthase (NOS), a constitutive enzyme that converts arginine to the free radical NO plus citrulline in the presence of NADPH and other cofactors. Endothelial (NOS) is a constitutive enzyme in vascular endothelial cells, it is activated by cholinergic stimulation. The NO produced diffuses to overlying vascular smooth muscle and activates soluble guanylate cyclase with the subsequent formation of cyclic GMP (cGMP) (1). NO interacts with the heme group in soluble guanylate cyclase altering its conformation, thereby activating the enzyme that converts guanine triphosphate into cGMP. cGMP then relaxes the overlying smooth muscle (2).Another constitutive isoform of NOS, neural (n) NOS, has been found in various parts of the central and peripheral nervous systems where it acts as a gaseous neurotransmitter (3, 4). In the hypothalamus, it activates the release of luteinizing hormone-releasing hormone that induces sexual behavior on the one hand, and release of luteinizing hormone on the other, both of which are required for reproduction (5, 6).In the periphery, terminals of NOergic neurons are also present in the corpora cavernosa penis and release of NO from these terminals activates guanylate cyclase in the smooth muscle causing relaxation, a requirement for penile erection (7). In ut...